Home > Financial Ratios > GLAND PHARMA
AD     Remove this Ad

GLAND PHARMA Last 5 Year EV/EBIT History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/EBIT(x) 21.6824.8716.1331.1828.05

What is the latest EV/EBIT ratio of GLAND PHARMA ?

The latest EV/EBIT ratio of GLAND PHARMA is 21.68 based on Mar2025 Consolidated results.
Year EV/EBIT
Mar202521.68
Mar202424.87
Mar202316.13
Mar202231.18
Mar202128.05

How is EV/EBIT of GLAND PHARMA Trending?

Years EV/EBIT % Change
Mar2025 21.68
-12.83
Mar2024 24.87
54.18
Mar2023 16.13
-48.27
Mar2022 31.18
11.16
Mar2021 28.05 -

Other Financial Ratios of GLAND PHARMA


Compare EV/EBIT ratio of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹28,245.9 Cr -1.6% -5.3% 5.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹412,326.0 Cr -5.7% -3.3% -2.1% Stock Analytics
DIVIS LABORATORIES ₹155,282.0 Cr -3.1% -9.3% 0% Stock Analytics
TORRENT PHARMACEUTICALS ₹137,043.0 Cr -6.1% -8.3% 23.7% Stock Analytics
DR REDDYS LABORATORIES ₹99,854.2 Cr -5.1% -6% 4.8% Stock Analytics
CIPLA ₹97,115.7 Cr -3.3% -11.2% -19.5% Stock Analytics


GLAND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

-1.6%

-5.3%

5.2%

SENSEX

1.4%

-7%

-3.9%


You may also like the below Video Courses